Form D · Pharmaceuticals
TP Therapeutics, Inc.
San Diego, CA · CIK 0001595893
Offering snapshot reported Oct 30, 2018 · SEC filing
- Reported sold
- $80M Offering amount: $80M
- Investors reported
- 16 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 18, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 30, 2018 | Initial | $80,000,016 | No comparison | 16 | SEC filing |
| May 25, 2017 | Initial | $45,000,017 | No comparison | 13 | SEC filing |
| Jan 6, 2014 | Initial | $1,429,999 | No comparison | 8 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-324635
Source: Form D, filed Oct 30, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Robert Adelman | Director |
| Bihua Chen | Director |
| Athena Maria Countouriotis | Director, Executive |
| Jingrong Cui | Director, Executive |
| Kenneth Fong | Director |
| Simeon George | Director |
| Carl Gordon | Director |
| Sheila K. Gujrathi | Director |
| George Lee | Director |
| Yishan Li | Director |
| Hongbo Lu | Director |
| Lewis J. Shuster | Director |
| Brett Zbar | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
10628 Science Center Drive, Suite 225
San Diego, CA, 92121
San Diego, CA, 92121